🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 26 week randomized controlled study. The study consists of, in or...
Status
Completed
Location
VA WNY Healthcare System
Start Date
2010-09
Trial ID
NCT01186822
Treatments Being Tested
A phase IV study to characterize safety of Elunate® (Fruquintinib) in Chine...
Status
Completed
Location
Shanghai Dongfang Hospital
Start Date
2019-04-20
Trial ID
NCT04005066
Treatments Being Tested
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
The purpose of this study is to compare the free time to disease progressio...
Status
Completed
Location
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Start Date
2006-07
Trial ID
NCT00335595
Summary In patients with prostate cancer (PC) who have only biochemically ...
Status
Unknown
Location
Copenhagen University hospital, Rigshospitalet
Start Date
2009-02
Trial ID
NCT03119857
Treatments Being Tested
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-06-05
Trial ID
NCT05762419
Treatments Being Tested
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
This is a Phase I, proof-of-concept treatment study to evaluate the safety,...
Status
Completed
Location
Johns Hopkins Outpatient Center
Start Date
2019-04-17
Trial ID
NCT03792516
Treatments Being Tested